Research ArticleArticle
The Bcl-2 Homology Domain 3 Mimetic ABT-737 Targets the Apoptotic Machinery in Acute Lymphoblastic Leukemia Resulting in Synergistic in Vitro and in Vivo Interactions with Established Drugs
Laura M. High, Barbara Szymanska, Urszula Wilczynska-Kalak, Nicole Barber, Rosemary O'Brien, Seong Lin Khaw, Ingela B. Vikstrom, Andrew W. Roberts and Richard B. Lock
Molecular Pharmacology March 2010, 77 (3) 483-494; DOI: https://doi.org/10.1124/mol.109.060780
Laura M. High
Barbara Szymanska
Urszula Wilczynska-Kalak
Nicole Barber
Rosemary O'Brien
Seong Lin Khaw
Ingela B. Vikstrom
Andrew W. Roberts
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
The Bcl-2 Homology Domain 3 Mimetic ABT-737 Targets the Apoptotic Machinery in Acute Lymphoblastic Leukemia Resulting in Synergistic in Vitro and in Vivo Interactions with Established Drugs
Laura M. High, Barbara Szymanska, Urszula Wilczynska-Kalak, Nicole Barber, Rosemary O'Brien, Seong Lin Khaw, Ingela B. Vikstrom, Andrew W. Roberts and Richard B. Lock
Molecular Pharmacology March 1, 2010, 77 (3) 483-494; DOI: https://doi.org/10.1124/mol.109.060780
Research ArticleArticle
The Bcl-2 Homology Domain 3 Mimetic ABT-737 Targets the Apoptotic Machinery in Acute Lymphoblastic Leukemia Resulting in Synergistic in Vitro and in Vivo Interactions with Established Drugs
Laura M. High, Barbara Szymanska, Urszula Wilczynska-Kalak, Nicole Barber, Rosemary O'Brien, Seong Lin Khaw, Ingela B. Vikstrom, Andrew W. Roberts and Richard B. Lock
Molecular Pharmacology March 1, 2010, 77 (3) 483-494; DOI: https://doi.org/10.1124/mol.109.060780
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement